Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis ; volume:9 ; number:1 ; day:13 ; month:4 ; year:2018 ; pages:1-18 ; date:12.2018
Nature Communications ; 9, Heft 1 (13.4.2018), 1-18, 12.2018

Creator: Angelini, Alessandro

Contributor: Miyabe, Yoshishige
Newsted, Daniel
Kwan, Byron H.
Miyabe, Chie
Kelly, Ryan L.
Jamy, Misha N.
Luster, Andrew D.
Wittrup, K. Dane
SpringerLink (Online service)

DOI: 10.1038/s41467-018-03687-x

URN: urn:nbn:de:101:1-2018061422345368039882

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Angelini, Alessandro
Miyabe, Yoshishige
Newsted, Daniel
Kwan, Byron H.
Miyabe, Chie
Kelly, Ryan L.
Jamy, Misha N.
Luster, Andrew D.
Wittrup, K. Dane
SpringerLink (Online service)

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1

A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins

GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs

Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

Determination of the frequency of individuals with broadly cross-reactive neutralizing antibodies against PRRSV in the sow population under field conditions

Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Plasmonic Cross‐Reactive Sensing Noses and Tongues

Efficacious nanomedicine track toward combating COVID-19

Related objects

Reset password